Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/22213
Full metadata record
DC FieldValueLanguage
dc.contributor.authorElias, Alby-
dc.contributor.authorCummins, Tia-
dc.contributor.authorLamb, Fiona-
dc.contributor.authorTyrrell, Regan-
dc.contributor.authorDore, Vincent-
dc.contributor.authorWilliams, Rob-
dc.contributor.authorRosenfeld, Jeffrey V-
dc.contributor.authorHopwood, Malcolm-
dc.contributor.authorVillemagne, Victor L-
dc.contributor.authorRowe, Christopher C-
dc.date2019-11-18-
dc.date.accessioned2019-12-04T05:00:32Z-
dc.date.available2019-12-04T05:00:32Z-
dc.date.issued2020-
dc.identifier.citationJournal of Alzheimer's disease : JAD 2020; 73(1): 163-173en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/22213-
dc.description.abstractEpidemiological studies suggest a relationship between posttraumatic stress disorder (PTSD) and dementia. This study assessed whether Alzheimer's disease (AD) imaging biomarkers were elevated in Vietnam veterans with PTSD. The study compared cognition, amyloid-β, tau, regional brain metabolism and volumes, and the effect of APOE in 83 veterans with and without PTSD defined by the Clinician's Administered PTSD Scale. The PTSD group had significantly lower education, predicted premorbid IQ, total intracranial volume, and Montreal Cognitive Assessment score compared with the controls. There was no difference between the two groups in the imaging or genetic biomarkers for AD. Our findings do not support an association between AD pathology and PTSD of up to 50 years duration. Measures to assess cognitive reserve, a factor that may delay the onset of dementia, were lower in the PTSD group compared with the controls and this may account for the previously observed higher incidence of dementia with PTSD.en
dc.language.isoeng-
dc.subjectAlzheimer’s diseaseen
dc.subjectamyloiden
dc.subjectbiomarkersen
dc.subjectdementiaen
dc.subjectpositron emission tomographyen
dc.subjectposttraumatic stress disorderen
dc.subjecttauen
dc.titleAmyloid-β, Tau, and 18F-Fluorodeoxyglucose Positron Emission Tomography in Posttraumatic Stress Disorder.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of Alzheimer's disease : JADen
dc.identifier.affiliationDepartment of Neurosurgery, Alfred Hospital, Melbourne, VIC, Australiaen
dc.identifier.affiliationCommonwealth Scientific and Industrial Research Organization (CSIRO), Australiaen
dc.identifier.affiliationDepartment of Surgery, Monash University, VIC, Australiaen
dc.identifier.affiliationMolecular Imaging and Therapyen
dc.identifier.affiliationDepartment of Psychiatry, The University of Melbourne, VIC, Australiaen
dc.identifier.affiliationFlorey Institute of Neuroscience and Mental Health, VIC, Australiaen
dc.identifier.doi10.3233/JAD-190913en
dc.type.contentTexten
dc.identifier.pubmedid31771068-
dc.type.austinJournal Article-
local.name.researcherLamb, Fiona
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptMolecular Imaging and Therapy-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

56
checked on Nov 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.